Focused Wealth Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,827
Closed -$28.6K 407
2023
Q4
$28.6K Sell
2,827
-378
-12% -$3.32K ﹤0.01% 385
2023
Q3
$25K Sell
3,205
-50
-2% -$429 ﹤0.01% 388
2023
Q2
$26.8K Hold
3,255
﹤0.01% 384
2023
Q1
$23.6K Buy
3,255
+294
+10% +$2.61K ﹤0.01% 418
2022
Q4
$26.3K Sell
2,961
-325
-10% -$3.57K 0.01% 384
2022
Q3
$40K Sell
3,286
-60
-2% -$935 0.01% 309
2022
Q2
$40K Hold
3,346
0.01% 314
2022
Q1
$64K Sell
3,346
-36
-1% -$669 0.01% 284
2021
Q4
$90K Sell
3,382
-70
-2% -$2.41K 0.01% 289
2021
Q3
$142K Sell
3,452
-250
-7% -$13.7K 0.02% 227
2021
Q2
$210K Sell
3,702
-839
-18% -$31K 0.03% 162
2021
Q1
$191K Sell
4,541
-1,980
-30% -$113K 0.03% 172
2020
Q4
$457K Sell
6,521
-3,603
-36% -$148K 0.09% 96
2020
Q3
$284K Sell
10,124
-2,320
-19% -$75.6K 0.06% 115
2020
Q2
$368K Sell
12,444
-119
-0.9% -$3.11K 0.09% 96
2020
Q1
$249K Sell
12,563
-5,242
-29% -$132K 0.07% 110
2019
Q4
$527K Sell
17,805
-1,804
-9% -$45.1K 0.12% 82
2019
Q3
$446K Sell
19,609
-3,679
-16% -$91.1K 0.12% 85
2019
Q2
$576K Sell
23,288
-2,903
-11% -$69.3K 0.15% 77
2019
Q1
$640K Buy
26,191
+1,742
+7% +$39.4K 0.19% 70
2018
Q4
$556K Sell
24,449
-2,737
-10% -$74.5K 0.19% 80
2018
Q3
$865K Buy
27,186
+797
+3% +$25.8K 0.29% 59
2018
Q2
$946K Buy
26,389
+15,439
+141% +$547K 0.33% 55
2018
Q1
$363K Buy
10,950
+130
+1% +$4.63K 0.12% 102
2017
Q4
$332K Buy
10,820
+1,095
+11% +$27.6K 0.11% 103
2017
Q3
$233K Buy
+9,725
New +$185K 0.08% 115

Other funds holding EDIT

Focused Wealth Management's EDIT Position: Q1 2024 in Review

Focused Wealth Management sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 2,827 shares — an estimated $28.6K sold.

Focused Wealth Management first reported a position in EDIT in Q3 2017 and held it in 26 quarters. The position peaked at $946K in Q2 2018. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

  • Focused Wealth Management reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 2,827 Editas Medicine shares in Q1 2024, an estimated $28.6K.
  • Focused Wealth Management first reported a position in Editas Medicine in Q3 2017 and held it in 26 quarters.
  • Focused Wealth Management's Editas Medicine position peaked at $946K in Q2 2018.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.